News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Trial shows delayed cord clamping difference
Small changes can sometimes have big impacts – just ask Drs Doug Blank and Shiraz Badurdeen. Their clinical trial of delayed cord clamping proved that a simple change to the way newborn babies are handled can make a huge difference to their lives.… Read more
-
Can IBD be cured?
This inflammatory condition affecting the digestive system can seriously impact people’s lives – so what is Crohn’s disease and how is it treated?… Read more
-
Family’s community rallies for hope from cancer research
When the Lindner family generously requested donations to Hudson Institute’s paediatric brain cancer research in lieu of flowers after the passing of their daughter Jessica, their community rallied behind their wish. … Read more
-
Searching for clues to how RNA triggers the immune system
A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.… Read more
-
Importance of donor age in treating BPD
An effective treatment is closer than ever for one of the most devastating conditions affecting premature babies, with researchers at Hudson Institute further refining their world-first method of treating BPD (Bronchopulmonary dysplasia).… Read more
-
Hudson Institute welcomes childhood cancer pledge
As a global leader in the field of childhood cancer research, Hudson Institute of Medical Research welcomes the Victorian Government’s pledge to invest $35 million in this area of vital need.… Read more
-
Cerebral palsy research awarded NHMRC Investigator Grant
Head of The Ritchie Centre, Professor Suzanne Miller, has been awarded more than $2.3 million to continue her groundbreaking work on targeted neuroprotective treatments for fetal and neonatal brain injury, primarily cerebral palsy… Read more
-
Modifying gut bacteria to treat IBD
Hudson Institute’s Dr Samuel Forster has received a highly prestigious fellowship to advance his work using the bacteria of the human microbiome to treat Inflammatory bowel disease (IBD).… Read more
-
Molecule heralds a microscopic bowel cancer breakthrough
The immune system wages a constant war against disease in all of us, and now researchers have identified a key immune molecule that could underpin a bowel cancer breakthrough.… Read more
-
Blood cancer: ask the researcher
Dr Catherine Carmichael answers frequently asked questions about blood cancer. Dr Carmichael is a molecular cancer biologist and Head of the Leukaemia Modelling and Therapeutic Discovery Research group within the Centre for Cancer Research at Hudson Institute.… Read more